Vitamin B6 Test · Blood

If your routine labs come back clean but you still feel fatigued, foggy, or worried about your long-term health, there is a blind spot in standard testing worth knowing about. Vitamin B6 is not included on any standard blood panel, yet population data from over 12,000 U.S. adults show that people with the lowest blood levels face roughly 37% higher risk of dying from any cause compared to those with adequate levels.

Your body cannot make B6 on its own. You get it from food (meat, fish, chickpeas, potatoes, bananas) and your liver converts it into its working form, PLP (pyridoxal 5' phosphate). PLP is the molecule this test actually tracks. It serves as a helper molecule for over 150 enzymes, touching nearly every system in your body, from building serotonin in your brain to breaking down the amino acids in the steak you had for dinner.

What PLP Does in Your Body

PLP is involved in so many reactions that low levels create a kind of metabolic traffic jam. It helps your cells build neurotransmitters (chemical messengers in the brain) like serotonin, dopamine, and GABA (gamma aminobutyric acid, the brain's main calming chemical). It is essential for breaking down and recycling amino acids, the building blocks of protein.

PLP plays a direct role in one-carbon metabolism, a biochemical recycling system your cells use to build DNA and regulate gene activity, working alongside folate (vitamin B9) and vitamin B12. It also helps your body release stored sugar from muscle and liver for energy, process fats, and keep homocysteine (a molecule linked to heart disease when elevated) from building up in your blood.

A controlled depletion study in 23 healthy adults confirmed that even marginal B6 deficiency, not outright zero intake but just not quite enough, caused widespread disruption across dozens of metabolic pathways.

Heart Disease and Cardiovascular Mortality

The link between low B6 and heart disease risk is one of the most consistent findings in this biomarker's research. In a large U.S. population study of over 12,000 adults followed for about 11 years, each step up in PLP level was associated with progressively lower risk of dying from cardiovascular causes. People in the top quarter had about 38% lower cardiovascular mortality compared to those in the bottom quarter, after adjusting for age, sex, smoking, BMI, and other risk factors.

In the Shanghai Men's and Women's Health Studies, which followed over 134,000 adults for 10 to 16 years, those with the highest dietary B6 intake had roughly 27% lower cardiovascular death risk in men and 20% lower in women compared to the lowest intake group. Stroke risk was even more dramatically different, about 29% lower in men and 28% lower in women.

A Dutch study of over 6,200 adults without cardiovascular disease (the PREVEND study) found that higher PLP was linked to about 34% lower risk of cardiovascular events. However, the association weakened after accounting for inflammation markers, suggesting that part of what PLP tracks is your body's overall inflammatory burden.

If your PLP comes back low, the next step is checking your hs-CRP (high-sensitivity C-reactive protein) and homocysteine alongside it. A low PLP with elevated hs-CRP points toward inflammation driving the number down, which is clinically different from a low PLP caused by genuinely insufficient intake.

Cancer Risk

A major meta-analysis pooling 121 observational studies and over 1.9 million participants found that people with the highest dietary B6 intake had about 22% lower overall cancer risk compared to those with the lowest intake. When researchers looked at blood PLP levels directly, the association was even stronger: those in the top category had roughly 34% lower cancer risk.

The most striking results were for gastrointestinal cancers. People with the highest PLP levels had about 44% lower risk of stomach, colon, and related cancers compared to the lowest group. For pancreatic cancer specifically, a separate meta-analysis found that every 10 nmol/L increase in blood PLP was associated with a 9% decrease in risk.

There is an important caveat. When researchers looked at total B6 intake (food plus supplements combined) rather than food alone, the protective associations weakened or disappeared. And randomized trials of high-dose B vitamin supplements have not confirmed cancer prevention benefits. This pattern suggests that adequate B6 from a good diet may be a marker of overall dietary quality rather than a standalone shield against cancer. That does not make the test useless. It means a low PLP result should prompt you to look at your diet broadly, not just pop a pill.

Diabetes and Metabolic Health

Low B6 shows up repeatedly in people with type 2 diabetes, metabolic syndrome, and obesity. In a study of over 2,500 adults with type 2 diabetes from the U.S. NHANES survey, those with PLP above 63.6 nmol/L had 26% lower risk of dying from any cause compared to those in the lowest quarter (below 24.3 nmol/L). PLP also correlates positively with HDL cholesterol (the protective kind) and inversely with LDL cholesterol in large population data.

People with diabetes and low B6 face a double problem. Diabetes increases inflammation, which actively burns through your B6 stores faster. This creates a vicious cycle where the disease depletes the very nutrient that helps protect against its complications. If you have diabetes or prediabetes, checking your B6 level gives you one more lever to optimize.

Muscle Loss, Frailty, and Aging

A 2024 review of 31 human studies found that 25 of them showed a significant link between low B6 status and sarcopenia (age-related muscle loss), frailty, or higher death rates in older adults. Marginal deficiency is common in otherwise healthy older people. In Irish cohorts spanning ages 18 to 102, older adults consistently had lower PLP than younger adults, and those with poor riboflavin (vitamin B2) status had even lower PLP, averaging 55.4 nmol/L with riboflavin deficiency versus 76.4 nmol/L with optimal riboflavin.

Older adults also handle B6 differently after meals. A study comparing younger and older adults given the same B vitamin supplement found that older adults had a blunted plasma PLP response and higher catabolism of B6, meaning their bodies used it up faster. This suggests that the standard recommended intake of about 1.5 to 2 mg per day may not be enough for people over 65.

The B6 Turnover Signal

Your body breaks PLP down into a waste product called 4-pyridoxic acid (4-PA). The ratio of 4-PA to PLP, sometimes called the B6 turnover ratio, tells you how fast your body is burning through its B6 supply. A high turnover ratio (high 4-PA relative to PLP) is a red flag, even if your PLP alone looks borderline acceptable.

In a study of over 4,800 U.S. adults aged 60 and older, those in the top quarter of B6 turnover had more than double the risk of dying from any cause (about 2.3 times higher) and about double the risk of dying from cancer compared to those in the bottom quarter. The 4-PA/PLP ratio performed as a better predictor of mortality than PLP alone, because it captures the combination of high demand (from inflammation or disease) and limited supply.

When Results Can Be Misleading

Inflammation is the biggest confounder for this test. Active infection, surgery, a rheumatoid arthritis flare, or any condition that raises your CRP will push PLP down and 4-PA up, making it look like you are deficient when the real problem is that your body is consuming B6 faster during the inflammatory episode. A study of over 2,200 community adults found that those in the highest third of an inflammation score had PLP levels about 25% lower (61 vs. 80 nmol/L) than those in the lowest third, even after accounting for B6 intake.

Kidney function also matters. Reduced kidney filtration slows the clearance of 4-PA, artificially inflating the turnover ratio. If your eGFR (estimated glomerular filtration rate, a measure of kidney function) is low, your 4-PA levels may look worse than they actually are.

• Timing of supplements: If you took a B6-containing supplement within 12 to 24 hours of your blood draw, PLP can spike temporarily. Fast overnight and skip your supplement the morning of the test for the most reliable baseline.
• Oral contraceptives: Population data show that most current or former oral contraceptive users have PLP below 20 nmol/L, even at intakes meeting the standard recommendation. This likely reflects a real shift in B6 metabolism, not just a lab artifact.
• Isoniazid (tuberculosis medication): This drug directly binds to PLP and blocks its function. PLP levels in people taking isoniazid are often profoundly low, and high-dose pyridoxine (100 to 200 mg/day) is needed to restore them.
• Alkaline phosphatase (ALP): The enzyme ALP breaks down PLP in blood. People with unusually high ALP (from bone disease or liver conditions) may show lower PLP than expected.

Tracking Your Trend

A single PLP reading is a useful starting point, but the real value comes from tracking over time. The within-person variation for PLP is substantial: one study in patients not taking B6 supplements found an intra-individual coefficient of variation of about 45% over 84 days. That means your PLP can swing noticeably from one draw to the next based on recent diet, inflammation status, and other factors.

Get a baseline reading when you are feeling well, not during an illness or inflammatory flare. If your level is marginal or low and you make dietary changes or start a supplement, retest in 4 to 8 weeks to confirm that your intervention is actually working. After that, annual monitoring is reasonable for most people, or every 6 months if you are managing a chronic condition or actively supplementing.

Always draw your sample fasted and at least 12 hours after your last B6-containing supplement. And always use the same lab, since different laboratory testing methods can produce meaningfully different numbers for the same sample.

What to Do With an Abnormal Result

If your PLP comes back below 30 nmol/L, the first step is to rule out inflammation as the driver. Order hs-CRP and a complete blood count alongside your B6 retest. If CRP is elevated, your low PLP may partly reflect an inflammatory state that needs its own investigation rather than simple B6 deficiency.

If inflammation is not the explanation, evaluate your diet and any medications. Oral contraceptives, isoniazid, and long-term NSAID use have all been linked to lower PLP. Check homocysteine: if it is also elevated, that reinforces the case that your body's DNA-building and gene-regulating recycling system is genuinely starved for B6 (along with folate and B12). A full B vitamin panel including B12 and folate gives a more complete picture.

For values above the normal range, the most common cause is supplementation. Extremely high PLP (above 500 nmol/L) in someone not taking supplements raises the possibility of hypophosphatasia, a rare inherited condition where alkaline phosphatase is unusually low. If your ALP is persistently below the normal range and your PLP is very high, a genetics referral is worth considering.

If your PLP is low and you are experiencing tingling, numbness, or other neurological symptoms, the picture gets more complex. Both deficiency and excess of B6 can cause nerve damage. In the case of excess, it is almost always from chronic high-dose pyridoxine supplements (typically well above 100 mg per day for weeks or months). If you have been taking high-dose B6 and develop sensory symptoms, stop the supplement and retest. Symptoms often improve after discontinuation.